Familial Idiopathic Glomerular Disease due to a Unique Renal-Predominant Phenotype of MYH9-Related Disease: A Case Report
- PMID: 40503181
- PMCID: PMC12158415
- DOI: 10.1159/000546242
Familial Idiopathic Glomerular Disease due to a Unique Renal-Predominant Phenotype of MYH9-Related Disease: A Case Report
Abstract
Introduction: MYH9-related disease (MYH9-RD) is a rare genetic cause of proteinuric kidney disease. It typically manifests as a syndromic condition, presenting with macrocytic thrombocytopenia, sensorineural hearing loss (SNHL), chronic glomerulopathy, elevated liver enzymes, and early-onset bilateral cataracts. In accordance with CARE guidelines, we present a case report of a father and daughter with renal-predominant MYH9-RD due to a recently described missense variant affecting the head domain of non-muscle myosin heavy chain IIA.
Case presentations: Patient 1 was an 18-year-old woman with childhood proteinuria who presented with severely advanced kidney failure. Dialysis was initiated as a bridge to a living unrelated renal transplant (LURT). Family history was notable for proteinuric kidney disease in her father (patient 2). Eight years later, genetic testing identified a likely pathogenic missense variant in the head domain of the MYH9 gene (c.1271G>A, p.R424Q). A predictive structural model was obtained via AlphaFold Protein Structure Database, in which the mutation interrupts hydrogen bonding and π-cation interactions, likely leading to protein misfolding. Subsequent clinical screening revealed persistent mild thrombocytopenia and elevated liver enzymes, without cataracts or SNHL. Patient 2 was a 53-year-old man with childhood proteinuria who eventually presented with stage 4 chronic kidney disease and soon after underwent LURT. After patient 1's genetic diagnosis, he was confirmed to have the same mutation by genetic testing. Subsequent screening revealed mild thrombocytopenia and elevated liver enzymes with hepatic steatosis progressing to cirrhosis, without cataracts or SNHL.
Conclusion: The finding of this MYH9 p.R424Q variant confirmed a diagnosis of MYH9-RD in these patients. MYH9 variants affecting the head domain typically result in severe thrombocytopenia. This recently reported head domain variant caused severe renal manifestations with mild thrombocytopenia and no manifestations of SNHL or cataracts in both patients, suggesting that this variant causes a renal-predominant form of MYH9-RD.
Keywords: Case report; Genetics; Glomerular diseases; MYH9-related disease; Proteinuria.
© 2025 The Author(s). Published by S. Karger AG, Basel.
Conflict of interest statement
N.S.F. and K.B. have no conflicts of interest. A.B. received support from NIH-NIDDK [K08DK132511], the Gerstner Family Foundation, and the American Society of Nephrology and Kidney Cure Carl W. Gottschalk Research Scholar Award. J.G.N. received support from the NIH-NIDDK [K08DK132511] and the American Society of Nephrology and Kidney Cure’s Harold Amos Medical Faculty Development Award. S.S.-C. is supported by the Department of Defense grant [W81XWH-22-1-0966] and by the National Institute of Health Grant [RC2-DK122397] and is an Associate Editor of Glomerular Diseases. P.A.C. is on the Editorial Board of Glomerular Diseases. Dr. Simone Sanna-Cherchi and Dr. Pietro A. Canetta were members of the journal’s Editorial Board at the time of submission.
Figures

Similar articles
-
Case Report: A Chinese family with MYH9-RD caused by MYH9 p.E1841K mutation exhibiting widespread may-hegglin inclusions.Front Pediatr. 2025 Jul 25;13:1588675. doi: 10.3389/fped.2025.1588675. eCollection 2025. Front Pediatr. 2025. PMID: 40787010 Free PMC article.
-
Severe Relapsing Hailey-Hailey Disease Displaying a Durable Complete Response to Hydroxyurea.Acta Dermatovenerol Croat. 2024 Nov;32(3):168-169. Acta Dermatovenerol Croat. 2024. PMID: 40654217
-
Thrombocytopenia, renal failure and hearing loss in a young patient: MYH9-related disorder.BMJ Case Rep. 2025 Jun 24;18(6):e262915. doi: 10.1136/bcr-2024-262915. BMJ Case Rep. 2025. PMID: 40555542 Free PMC article.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.Cochrane Database Syst Rev. 2013 Oct 8;(10):CD008944. doi: 10.1002/14651858.CD008944.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2019 Mar 11;3:CD008944. doi: 10.1002/14651858.CD008944.pub3. PMID: 24101439 Updated.
References
-
- Singh N, Nainani N, Arora P, Venuto RC. CKD in MYH9-related disorders. Am J Kidney Dis. 2009;54(4):732–40. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous